Long-term safety of glycopyrrolate/eFlow® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study

• Published in: Respiratory medicine Vol. 132; pp. 251 - 260
• Main Authors: Ferguson, Gary T., Goodin, Thomas, Tosiello, Robert, Wheeler, Alistair, Kerwin, Edward
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.11.2017; Elsevier Limited
• Subjects: Acetylcholine receptors (muscarinic); Antagonists; Bronchodilators; Chronic obstructive pulmonary disease; COPD; Cough; Drug therapy; eFlow® CS; Glycopyrrolate; Heart diseases; LAMA; Lung diseases; Medical equipment; Nebulizer; Obstructive lung disease; Patient safety; Respiratory function; Respiratory tract; Safety; SUN-101; SUN-101; Glycopyrrolate; LAMA; Safety; eFlow® CS; Nebulizer; COPD; eFlow(®) CS

The use of long-acting bronchodilators is an essential component of the management of chronic obstructive pulmonary disease (COPD). The GOLDEN 5 Phase III, randomized, active-controlled, open-label study was conducted to evaluate the long-term safety and tolerability of a nebulized glycopyrrolate fo...